These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29022506)

  • 41. Autologous bone marrow stem cell therapy for the ischemic myocardium during coronary artery bypass grafting.
    Yerebakan C; Kaminski A; Westphal B; Liebold A; Steinhoff G
    Minim Invasive Ther Allied Technol; 2008; 17(2):143-8. PubMed ID: 18465448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial.
    Yeo C; Mathur A
    Regen Med; 2009 Jan; 4(1):119-27. PubMed ID: 19105621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time course effect of hypoxia on bone marrow-derived endothelial progenitor cells and their effects on left ventricular function after transplanted into acute myocardial ischemia rat.
    Jian KT; Shi Y; Zhang Y; Mao YM; Liu JS; Xue FL
    Eur Rev Med Pharmacol Sci; 2015; 19(6):1043-54. PubMed ID: 25855931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular wall progenitor cells in health and disease.
    Psaltis PJ; Simari RD
    Circ Res; 2015 Apr; 116(8):1392-412. PubMed ID: 25858065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences.
    Pavo N; Charwat S; Nyolczas N; Jakab A; Murlasits Z; Bergler-Klein J; Nikfardjam M; Benedek I; Benedek T; Pavo IJ; Gersh BJ; Huber K; Maurer G; Gyöngyösi M
    J Mol Cell Cardiol; 2014 Oct; 75():12-24. PubMed ID: 24998410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia.
    Kawamoto A; Murayama T; Kusano K; Ii M; Tkebuchava T; Shintani S; Iwakura A; Johnson I; von Samson P; Hanley A; Gavin M; Curry C; Silver M; Ma H; Kearney M; Losordo DW
    Circulation; 2004 Sep; 110(11):1398-405. PubMed ID: 15337699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: systematic review and meta-analysis of large animal studies.
    Jansen Of Lorkeers SJ; Eding JE; Vesterinen HM; van der Spoel TI; Sena ES; Duckers HJ; Doevendans PA; Macleod MR; Chamuleau SA
    Circ Res; 2015 Jan; 116(1):80-6. PubMed ID: 25186794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.
    Kawamoto A; Asahara T
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):477-84. PubMed ID: 17894361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frontiers in nephrology: the evolving therapeutic applications of endothelial progenitor cells.
    Tongers J; Losordo DW
    J Am Soc Nephrol; 2007 Nov; 18(11):2843-52. PubMed ID: 17942950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diazoxide preconditioning of endothelial progenitor cells improves their ability to repair the infarcted myocardium.
    Mehmood A; Ali M; Khan SN; Riazuddin S
    Cell Biol Int; 2015 Nov; 39(11):1251-63. PubMed ID: 26032287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cell-based therapeutic angiogenesis for the treatment of ischemic disease].
    Hamano K; Li TS
    Nihon Geka Gakkai Zasshi; 2004 Aug; 105(8):464-8. PubMed ID: 15373224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Fisher SA; Brunskill SJ; Doree C; Mathur A; Taggart DP; Martin-Rendon E
    Cochrane Database Syst Rev; 2014 Apr; (4):CD007888. PubMed ID: 24777540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin-3 greatly expands non-adherent endothelial forming cells with pro-angiogenic properties.
    Moldenhauer LM; Cockshell MP; Frost L; Parham KA; Tvorogov D; Tan LY; Ebert LM; Tooley K; Worthley S; Lopez AF; Bonder CS
    Stem Cell Res; 2015 May; 14(3):380-95. PubMed ID: 25900163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease.
    Yokoyama S; Fukuda N; Li Y; Hagikura K; Takayama T; Kunimoto S; Honye J; Saito S; Wada M; Satomi A; Kato M; Mugishima H; Kusumi Y; Mitsumata M; Murohara T
    J Mol Cell Cardiol; 2006 Jan; 40(1):24-34. PubMed ID: 16271723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myocardial homing and coronary endothelial function after autologous blood CD34+ progenitor cells intracoronary injection in the chronic phase of myocardial infarction.
    Dedobbeleer C; Blocklet D; Toungouz M; Lambermont M; Unger P; Degaute JP; Goldman S; Berkenboom G
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):480-5. PubMed ID: 19433985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Possibilities for cardiovascular gene therapy].
    Szelid ZL; Pokreisz P; Janssens S; Polák G
    Orv Hetil; 2005 May; 146(22):1189-96. PubMed ID: 15997664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progenitor cells from atria, ventricle and peripheral blood of the same patients exhibit functional differences associated with cardiac repair.
    Dixit P; Donnelly H; Edamatsu M; Galvin I; Bunton R; Katare R
    Int J Cardiol; 2017 Feb; 228():412-421. PubMed ID: 27875722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BM ageing: Implication for cell therapy with EPCs.
    Rurali E; Bassetti B; Perrucci GL; Zanobini M; Malafronte C; Achilli F; Gambini E
    Mech Ageing Dev; 2016 Oct; 159():4-13. PubMed ID: 27045606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation.
    Cheung C; Sinha S
    J Mol Cell Cardiol; 2011 Nov; 51(5):651-64. PubMed ID: 21816157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Strategies to Overcome the Barrier of Ischemic Microenvironment in Cell Therapy of Cardiovascular Disease.
    Berndt R; Albrecht M; Rusch R
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.